Spina bifida is a type of neural tube defect (NTD) that affects the development of the spine and spinal cord. It typically becomes apparent at birth and occurs when the neural tube fails to close completely during early fetal development. This results in part of the spine remaining open, potentially exposing and damaging the spinal cord and surrounding nerves.
The severity of spina bifida varies widely, depending on the size, location of the defect, and whether the spinal cord or nerves are involved.
While the exact cause is unknown, several factors are associated with an increased risk:
Spina bifida presents in different forms, each with varying degrees of severity:
1. Myelomeningocele (Most severe form)
2. Meningocele (Moderate form)
3. Spina Bifida Occulta (Mildest form)
Diagnosis of SB-Spina bifida
Spina bifida is commonly detected during mid-pregnancy ultrasound screening (typically between 18–21 weeksgestation). If identified, the healthcare team will provide counseling on prognosis, treatment options, and delivery planning.
Postnatal assessment may include:
BBH Functional Rehabilitation Program
Since 2005, BBH has been developing integrative protocols combining stem cell therapy with condition-specific rehabilitation. Our approach targets both the symptoms and the root cause of spina bifida by supporting neurological recovery and improving patients’ quality of life.
This program includes:
With timely treatment and support, many individuals with spina bifida can live well into adulthood with a good quality of life.
Program Recommendations for SB-Spina bifida
12 September 2025
Viewed 224 times